Dexa Group

dexagroup logo desktop hut 54 dexa en

Move Together, Grab Opportunities

For more than five decades, Dexa Group has been committed to the promotion of health through the safety, quality, and efficacy of medicinal products.

From Molecule, to Market

Building end-to-end competency in pharmaceutical discovery, formulation, manufacturing, and marketing across four continents: Asia, Africa, Europe, and America.

Dexa means Quality

Our name was inspired by the Greek δέκα, meaning 10 — a universal symbol of perfection. Even today, our work aspires to that same impossible standard. That’s why, for millions of people in 14 countries, Dexa means quality.

Indonesian Modern Herbal Medicines

We identify, extract, and test biomolecules embedded deep in nature. Then, we use these microscopic gems to produce herbal medicines that are extraordinarily safe and effective.

Dexa: A Snapshot




Pharmacies Covered Directly

International Alliances

Marketing Authorisations

Latest News

11 September 2023

Dexa Medica and the Indonesian National Army (TNI AD) Collaborate to Reduce Stunting

Dexa Medica continues collaborating with diverse stakeholders to play an active role in the program to reduce stunting to 14% by 2024. Dexa Medica collaborated with the Indonesian National Army (TNI AD) and the Family Coordinating Agency National Planning (BKKBN) on this occasion to launch the e-Stuntad and e-Posyandu apps…
6 September 2023

Dexa Medica Halal Product Guarantee System Wins Halal Award

Dexa Group once again received the Halal Award from the Lembaga Pengkajian Pangan Obat-obatan dan Kosmetika Majelis Ulama Indonesia (LPPOM MUI) in the Best Social Contribution on Halal environment category, demonstrating its dedication to establishing a halal environment in Indonesia. "I congratulate all companies and business actors nominated for and…
29 August 2023

Dexa Medica Contributes to PIT IAI, Support Advancement, and Faces Pharmaceutical Challenges

Dexa Medica participated in the Annual Scientific Meeting (PIT) of the Ikatan Apoteker Indonesia (IAI) in Solo City, Central Java, on August 24 -26, 2023, as a form of collaboration in supporting advancement and facing challenges in the pharmaceutical and health fields in accordance with the Dexa Medica's core purpose,…
23 August 2023

BKKBN and Dexa Medica Educate Blitar Midwife on The Importance of Breast Milk in Overcoming Stunting

In the 2024 Rancangan Anggaran Belanja dan Pendapatan Negara (RAPBN), President Joko Widodo allotted IDR 186.4 trillion, or 5.6 percent, towards the healthcare system. One of the primary goals is to reduce the prevalence of stunting in Indonesia by 14 percent by 2024. In this context, Hasto Wardoyo, the Head…
28 June 2023

Commitment to Accelerate Stunting Reduction Prevalence to 14%, Dexa Medica and BKKBN Educate Thousand of Midwives

Various parties are involved in the pentahelix collaboration to pursue the stunting reduction target of 14% by 2024. To continue pursuinh the stunting reduction target set by President Joko Widodo, the National Population and Family Planning Agency (BKKBN) collaborated with Dexa Medica and the South Sumatra Provincial Government to hold…